New York State Common Retirement Fund Citius Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $76.2 Billion
- Q2 2024
A detailed history of New York State Common Retirement Fund transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,134 shares of CTXR stock, worth $567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,134
Previous 77,990
98.55%
Holding current value
$567
Previous $70,000
98.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
30.6MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY10.2MShares$5.08 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.33MShares$3.16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.02 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$902,8630.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.65MShares$823,1480.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $73.1M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...